Humaniche is an ETH Zürich spin-off in formation, developing a family of off-the-shelf and disease-specific human bone marrow niche proxy kits and in vitro systems that provide structured insights into efficacy and hematopoietic toxicity at the stage immediately prior to first-in-human trials, where development risk and capital exposure are highest. Until now, it has raised CHF 588K in non-dilutive funding. By introducing functional human bone marrow biology into late preclinical decision-making, Humaniche reduces costly late-stage clinical failures and supports the pharmaceutical industry’s transition toward validated New Approach Methodologies (NAMs). By developing human-relevant, scalable, and reproducible bone marrow disease model tools, Humanishe aims to enable safer, more effective advanced therapies to efficiently reach blood cancer patients.
Staff Scientist & Lead of Image Analysis at the Scientific Center for Optical & Electron Microscopy at ETH Zurich, and Independent Consultant at Harvard Medical School working at the multidisciplinary interface of Life Sciences and Computer Science. Focused on Bioimage Analysis and Artificial Intelligence.
Ex-CEO and Serial Entrepreneur & Investor specializing in IT companies and startups applying Computer Vision and Machine Learning in Pharma, Microscopy, and Robotics.
Before ETH Zurich and Harvard Medical School, I worked on R&D projects in the French Institute for Research in Computer Science and Automation (INRIA), Massachusetts Institute of Technology (MIT), and Humboldt University Berlin (HUB).
Ex-CEO of Tooploox Research (tooploox.com) - previously known as MicroscopeIT - a software house specializing in R&D, AI, and Computer Vision. Successfully led the merger with Tooploox (www.tooploox.com), scaling the organization to 180 employees. Head of the R&D department of the Tooploox group, overseeing a team of 30+ researchers and staff engineers. Former CSO of Cat-astrophe Games Studio (www.cat-astrophe-games.com), an indy game studio focused on AR applications.
ETH Zurich ScopeM offers access to advanced light, electron and correlative microscopy, together with expert support in bioimage analysis, segmentation, quantification and AI-assisted microscopy workflows.